Amphastar Pharmaceuticals Price to Book Ratio 2012-2026 | AMPH
Historical price to book ratio values for Amphastar Pharmaceuticals (AMPH) over the last 10 years. The current price to book ratio for Amphastar Pharmaceuticals as of May 08, 2026 is 1.19.
| Amphastar Pharmaceuticals Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2026-05-11 | 18.45 | 0.00 | |
| 2026-03-31 | 19.59 | 0.00 | |
| 2025-12-31 | 26.78 | 0.00 | |
| 2025-09-30 | 26.65 | $16.76 | 1.59 |
| 2025-06-30 | 22.96 | $16.29 | 1.41 |
| 2025-03-31 | 28.99 | $15.76 | 1.84 |
| 2024-12-31 | 37.13 | $15.38 | 2.41 |
| 2024-09-30 | 48.53 | $15.04 | 3.23 |
| 2024-06-30 | 40.00 | $14.57 | 2.75 |
| 2024-03-31 | 43.91 | $13.77 | 3.19 |
| 2023-12-31 | 61.85 | $13.30 | 4.65 |
| 2023-09-30 | 45.99 | $12.43 | 3.70 |
| 2023-06-30 | 57.47 | $12.07 | 4.76 |
| 2023-03-31 | 37.50 | $11.39 | 3.29 |
| 2022-12-31 | 28.02 | $10.99 | 2.55 |
| 2022-09-30 | 28.10 | $10.39 | 2.70 |
| 2022-06-30 | 34.79 | $10.19 | 3.41 |
| 2022-03-31 | 35.90 | $9.84 | 3.65 |
| 2021-12-31 | 23.29 | $9.34 | 2.49 |
| 2021-09-30 | 19.01 | $8.97 | 2.12 |
| 2021-06-30 | 20.16 | $9.74 | 2.07 |
| 2021-03-31 | 18.32 | $9.45 | 1.94 |
| 2020-12-31 | 20.11 | $9.45 | 2.13 |
| 2020-09-30 | 18.75 | $9.49 | 1.98 |
| 2020-06-30 | 22.46 | $9.32 | 2.41 |
| 2020-03-31 | 14.84 | $9.14 | 1.62 |
| 2019-12-31 | 19.29 | $9.18 | 2.10 |
| 2019-09-30 | 19.83 | $9.19 | 2.16 |
| 2019-06-30 | 21.11 | $9.16 | 2.31 |
| 2019-03-31 | 20.43 | $8.07 | 2.53 |
| 2018-12-31 | 19.90 | $7.81 | 2.55 |
| 2018-09-30 | 19.24 | $7.39 | 2.60 |
| 2018-06-30 | 15.26 | $6.91 | 2.21 |
| 2018-03-31 | 18.75 | $7.01 | 2.67 |
| 2017-12-31 | 19.24 | $7.16 | 2.69 |
| 2017-09-30 | 17.87 | $7.20 | 2.48 |
| 2017-06-30 | 17.86 | $7.21 | 2.48 |
| 2017-03-31 | 14.50 | $7.08 | 2.05 |
| 2016-12-31 | 18.42 | $7.12 | 2.59 |
| 2016-09-30 | 18.97 | $7.13 | 2.66 |
| 2016-06-30 | 16.12 | $6.82 | 2.36 |
| 2016-03-31 | 12.00 | $6.60 | 1.82 |
| 2015-12-31 | 14.23 | $6.54 | 2.18 |
| 2015-09-30 | 11.69 | $6.28 | 1.86 |
| 2015-06-30 | 17.58 | $6.29 | 2.79 |
| 2015-03-31 | 14.96 | $6.25 | 2.39 |
| 2014-12-31 | 11.61 | $6.31 | 1.84 |
| 2014-09-30 | 11.65 | $6.34 | 1.84 |
| 2014-06-30 | 10.01 | $6.45 | 1.55 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $0.924B | $0.720B |
| Amphastar Pharmaceuticals, Inc. is a specialty pharmaceutical company. It focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable and inhalation products. The company products include Enoxaparin Sodium Injection; Amphadase; Cortrosyn for Injection; and prefilled disposable emergency syringes for crash cart use. Amphastar Pharmaceuticals, Inc. is headquartered in Rancho Cucamonga, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Bausch Health Cos (BHC) | Canada | $2.086B | 1.50 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |